Rapid Micro Biosystems Announces Appointment of Kirk Malloy, Ph.D. as Chair of its Board of Directors

LOWELL, Mass., July 18, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, is pleased to announce the appointment of Kirk Malloy, Ph.D. as Chair of the Company’s Board of Directors (the “Board”). Dr. Malloy will also Chair the Board’s Compensation Committee. Jeffrey Schwartz, who

Related Keywords

Massachusetts ,United States ,Boston University ,Switzerland ,Germany ,Northeastern University ,Netherlands ,Jeffrey Schwartz ,Robert Spignesi ,Michael Beaulieu ,Kirk Malloy ,Verogen Inc ,Company Growth ,Exchange Commission ,Company Annual Report On Form ,Dermtech Inc ,University Of Delaware ,Corporate Communications Media ,Linkedin ,Securities Exchange ,Schwartz ,Company On Twitter ,Biosite Inc ,University Of Miami ,Rapid Micro Biosystems Inc ,Corporate Governance Committee ,Company Board ,Qiagen Inc ,Board Compensation Committee ,Nasdaq ,Company Board Of Directors The ,Nanostring Technologies Inc ,Illumina Inc ,Micro Biosystems ,Board Chair ,Corporate Governance ,Chief Executive ,Chief Executive Officer ,Nanostring Technologies ,Marine Science ,Rapid Micro Biosystems ,Growth Direct ,Securities Act ,Securities Exchange Act ,Annual Report ,Investor Relations ,Investor Contact ,Corporate Communications ,